Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1618
    -0.0065 (-0.56%)
     
  • GBP/USD

    1.2379
    -0.0060 (-0.48%)
     
  • Bitcoin GBP

    52,024.80
    +1,222.29 (+2.41%)
     
  • CMC Crypto 200

    1,383.48
    +70.86 (+5.40%)
     
  • S&P 500

    4,978.72
    -32.40 (-0.65%)
     
  • DOW

    37,968.84
    +193.46 (+0.51%)
     
  • CRUDE OIL

    83.30
    +0.57 (+0.69%)
     
  • GOLD FUTURES

    2,409.40
    +11.40 (+0.48%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Emerson Launches ASCO Series 273 for Life Sciences Market

Emerson Electric Co. EMR recently unveiled ASCO Series 273 Pinch Valve for the life sciences market. With the release, the company has expanded its extensive pneumatic valve offering to single-use batch applications.

Developed for use with high-purity liquids in biotech applications, the Series 273 features a 2-way normally closed and normally open pressure-operated pinch valves. The product, which is available in 316 stainless steel and anodized aluminum, is appropriate for peroxide fumigation.

The Series 273’s advanced pinching mechanism offers improved tube retention apart from avoiding any damage to the soft tubing. It also incorporates a safety guard, which helps in preventing exposure to moving parts. Also, its manual override feature allows operators to insert or remove tubing without the need for actuating the valve. The improved valve design provides better safety to operators apart from enabling them to accelerate setup, in turn, reducing costs and making unscheduled maintenance simple.

Our Take

Emerson is experiencing persistent weakness in the global discrete manufacturing market due to soft automotive, semiconductor, packaging and textiles end markets. As a matter of fact, it expects the weakness to persist in the global discrete manufacturing market in the near term.

Also, rising costs and expenses have been an issue for the company over the past few quarters. It recorded year-over-year increase of 0.5% in the cost of sales in the fourth quarter of fiscal 2019 (ended Sep 30, 2019). In addition, in fiscal 2019 (ended Sep 30, 2019), the company's selling, general and administrative expenses jumped 4.4% year over year. Persistence of these headwinds might be concerning in the quarters ahead.

The Zacks Rank #5 (Strong Sell) company has gained 9.9% in the past month compared with the industry’s increase of 13.3%.

Stocks to Consider

Some better-ranked stocks from the Zacks Industrial Products sector are AZZ Inc. AZZ, Energous Corporation WATT and Dover Corporation DOV. All these companies carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

ADVERTISEMENT

AZZ delivered average positive earnings surprise of 2.12% in the trailing four quarters.

Energous pulled off average positive earnings surprise of 6.67% in the trailing four quarters.

Dover delivered average positive earnings surprise of 6.70% in the trailing four quarters.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
AZZ Inc. (AZZ) : Free Stock Analysis Report
 
Energous Corporation (WATT) : Free Stock Analysis Report
 
Emerson Electric Co. (EMR) : Free Stock Analysis Report
 
Dover Corporation (DOV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research